Dr. Jeffrey Charles Eickhoff, MD

Dr. Eickhoff practices at Grand Itasca Clinic & Hospital in Grand Rapids, Minnesota, part of Fairview Health Services.

Dr. Eickhoff's NPI, 1760744478, was assigned on June 10, 2012. Dr. Eickhoff graduated from Michigan State University College of Human Medicine in 2012. Dr. Eickhoff holds Minnesota license 67078.

Dr. Eickhoff's primary practice is Grand Itasca Clinic & Hospital, at 1601 Golf Course Road, Grand Rapids, MN 55744 in Itasca County. The practice phone is (218) 326-3401.

Dr. Eickhoff's primary practice is Grand Itasca Clinic & Hospital in Grand Rapids, Minnesota, part of Fairview Health Services. Dr. Eickhoff is also affiliated with Fairview Range Hospital. The medical group on file is Grand Itasca Clinic & Hospital. Dmand AI also links Dr. Eickhoff to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eickhoff practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Eickhoff's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Eickhoff's licenses on file in 2 states: Minnesota and Nebraska.

CMS data shows 838 Medicare services from Dr. Eickhoff across 4 procedure codes in 2024, for 205 Medicare patients. Medicare paid $48,507 for them. Every service was in an office.

CMS counts 205 Medicare patients who saw Dr. Eickhoff in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have arthritis, and 70% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eickhoff's median patient age at 71, with 69% women.

In 2024, Dr. Eickhoff wrote 2,377 Medicare Part D claims for 401 patients. 83% of them were for generic drugs. CMS names the drug for 2,244 of them, across 29 drugs with 11 or more claims each, at $1,678,434 in total drug cost. In 2023, CMS named 1,725 claims across 25 drugs.

Dr. Eickhoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eickhoff as offering telehealth.

Dmand AI links 5 papers to Dr. Eickhoff. Dr. Eickhoff has published most often in J Clin Rheumatol. Dr. Eickhoff's most frequent co-authors are Jess David Edison, MD, Joseph Maciuba, MD and Kaye Evelyn Sedarsky, MD.

CMS Open Payments shows 2 general payments to Dr. Eickhoff from 2 drug and device companies from 2017 to 2018. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $125.

Dr. Eickhoff graduated from Michigan State University College of Human Medicine in 2012.